Richmond Hill, NY1 Active Studies

Neuroendocrine Tumors Clinical Trials in Richmond Hill, NY

Find 1 actively recruiting neuroendocrine tumors clinical trials in Richmond Hill, NY. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
445
Enrolling

Recruiting Neuroendocrine Tumors Studies in Richmond Hill

About Neuroendocrine Tumors Clinical Trials in Richmond Hill

Neuroendocrine tumors (NETs) develop from hormone-producing cells and can occur in many organs, most commonly the gastrointestinal tract and lungs. They range from slow-growing to aggressive. Treatment includes surgery, somatostatin analogs, targeted therapy, and peptide receptor radionuclide therapy.

There are currently 1 neuroendocrine tumors clinical trials recruiting participants in Richmond Hill, NY. These studies are seeking a combined 445 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Neuroendocrine Tumors Clinical Trials in Richmond Hill — FAQ

Are there neuroendocrine tumors clinical trials in Richmond Hill?

Yes, there are 1 neuroendocrine tumors clinical trials currently recruiting in Richmond Hill, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Richmond Hill?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Richmond Hill research site will contact you about next steps.

Are clinical trials in Richmond Hill free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Richmond Hill studies also compensate for your time and travel.

What neuroendocrine tumors treatments are being tested?

The 1 active trials in Richmond Hill are testing new therapies including novel drugs, biologics, and treatment approaches for neuroendocrine tumors.

Data updated July 13, 2026 from ClinicalTrials.gov